公开(公告)号：WO0071507A3

公开(公告)日：2001-11-15

申请号：PCT/US0014196

申请日：2000-05-24

Applicant: COR THERAPEUTICS INC

Inventor： ZHU BING-YAN ,  SU TING ,  ZHAOZHONG JON JIA ,  SCARBOROUGH ROBERT M ,  SONG YONGHONG

IPC: A61P7/02 ,  A61K31/167 ,  A61K31/18 ,  A61K31/275 ,  A61K31/277 ,  A61K31/40 ,  A61K31/472 ,  A61K31/4725 ,  A61P9/00 ,  A61P9/04 ,  A61P9/10 ,  C07C311/16 ,  C07C311/18 ,  C07C311/40 ,  C07C311/44 ,  C07C311/46 ,  C07D207/16 ,  C07D217/22 ,  C07D401/06

CPC classification number: C07C311/40 ,  C07C311/16 ,  C07C311/18 ,  C07C311/44 ,  C07C311/46

Abstract: Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.

Abstract translation: 公开了与哺乳动物因子Xa具有活性的新型化合物，其盐和与其相关的组合物。 该化合物可用于体内或体内用于预防或治疗凝血障碍。

公开(公告)号：AU5283900A

公开(公告)日：2000-12-12

申请号：AU5283900

申请日：2000-05-24

Applicant: COR THERAPEUTICS INC

Inventor： ZHU BING-YAN ,  SU TING ,  ZHAOZHONG JON JIA ,  SCARBOROUGH ROBERT M JR ,  SONG YONGHONG

IPC: A61P7/02 ,  A61K31/167 ,  A61K31/18 ,  A61K31/275 ,  A61K31/277 ,  A61K31/40 ,  A61K31/472 ,  A61K31/4725 ,  A61P9/00 ,  A61P9/04 ,  A61P9/10 ,  C07C311/16 ,  C07C311/18 ,  C07C311/40 ,  C07C311/44 ,  C07C311/46 ,  C07D207/16 ,  C07D217/22 ,  C07D401/06 ,  C07C311/00

Abstract: Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.

公开(公告)号：CA2374646A1

公开(公告)日：2000-11-30

申请号：CA2374646

申请日：2000-05-24

Applicant: COR THERAPEUTICS INC

Inventor： ZHU BING-YAN ,  SU TING ,  SCARBOROUGH ROBERT M ,  SONG YONGHONG ,  ZHAOZHONG JON JIA

IPC: A61P7/02 ,  A61K31/167 ,  A61K31/18 ,  A61K31/275 ,  A61K31/277 ,  A61K31/40 ,  A61K31/472 ,  A61K31/4725 ,  A61P9/00 ,  A61P9/04 ,  A61P9/10 ,  C07C311/16 ,  C07C311/18 ,  C07C311/40 ,  C07C311/44 ,  C07C311/46 ,  C07D207/16 ,  C07D217/22 ,  C07D401/06

Abstract: Novel compounds, their salts and compositions related thereto having activit y against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.